Therapeutic guidelines for Pseudomonas aeruginosa infections
- 1 October 2000
- journal article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 16 (2) , 103-106
- https://doi.org/10.1016/s0924-8579(00)00212-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Survey of Bloodstream Infections Due to Gram-Negative Bacilli: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997Clinical Infectious Diseases, 1999
- Pseudomonas aeruginosa Bacteremia in Patients Infected with Human Immunodeficiency Virus Type 1European Journal of Clinical Microbiology & Infectious Diseases, 1999
- Antibiotic Susceptibility Among Aerobic Gram-negative Bacilli in Intensive Care Units in 5 European CountriesJAMA, 1999
- Science and pragmatism in the treatment and prevention of neutropenic infectionJournal of Antimicrobial Chemotherapy, 1998
- Antibiotic resistance in Pseudomonas aeruginosa: an Italian surveyJournal of Antimicrobial Chemotherapy, 1998
- Ventilator-associated Pneumonia Caused by Potentially Drug-resistant BacteriaAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Survival in patients with nosocomial pneumoniaCritical Care Medicine, 1997
- Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)Intensive Care Medicine, 1996
- The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory CommitteeJAMA, 1995
- Predominant pathogens in hospital infectionsJournal of Antimicrobial Chemotherapy, 1992